Related references
Note: Only part of the references are listed.The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019
Gislaine Fongaro et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2021)
Influenza and COVID-19: What does co-existence mean?
Tawee Chotpitayasunondh et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)
Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China
Minghuan Jiang et al.
VACCINE (2020)
Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran
Zohre Khodamoradi et al.
ARCHIVES OF IRANIAN MEDICINE (2020)
Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico
Guillermo M. Ruiz-Palacios et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
David Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina
Van Hung Nguyen et al.
VACCINE (2020)
SARS-CoV-2 and influenza virus co-infection
Elena Cuadrado-Payan et al.
LANCET (2020)
Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model
Pascal Crepey et al.
BMC PUBLIC HEALTH (2020)
Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017
Rakhee Palekar et al.
PLOS ONE (2019)
Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types
Laure-Anne Van Bellinghen et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2018)
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
Francesco Saverio Mennini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
Edward W. Thommes et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
A systematic review of the health economic consequences of quadrivalent influenza vaccination
Pieter T. de Boer et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America
Aurelien Jamotte et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
Dominic Thorrington et al.
BMC MEDICINE (2017)
The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
Lisa Nagy et al.
PHARMACOECONOMICS (2016)
Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
Pieter T. de Boer et al.
VALUE IN HEALTH (2016)
Evaluating the case for trivalent or quadrivalent influenza vaccines
David Baxter
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
Amos Garcia et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom
Edward W. Thommes et al.
BMC INFECTIOUS DISEASES (2015)
An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
Ayman Chit et al.
PLOS ONE (2015)
The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy
Deborah Cromer et al.
JOURNAL OF INFECTION (2014)
The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model
Laure-Anne Van Bellinghen et al.
PLOS ONE (2014)
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
Andrea C. Tricco et al.
BMC MEDICINE (2013)
Public health and economic benefits of new pediatric influenza vaccination programs in Argentina
Norberto Giglio et al.
Human Vaccines & Immunotherapeutics (2012)
Vaccines for preventing influenza in healthy children
Tom Jefferson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Clinical Efficacy of Cell Culture-Derived and Egg-Derived Inactivated Subunit Influenza Vaccines in Healthy Adults
Sharon Frey et al.
CLINICAL INFECTIOUS DISEASES (2010)
Vaccines for preventing influenza in the elderly
Tom Jefferson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Vaccines for preventing influenza in healthy adults
Tom Jefferson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example
Jiri Beran et al.
BMC INFECTIOUS DISEASES (2009)
Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April-July 2009
Carrie Reed et al.
EMERGING INFECTIOUS DISEASES (2009)
Burden of influenza in children in the community
T Heikkinen et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Share Paper
